Navigating Relapsed/Refractory CLL/SLL Together: Where Disease-, Treatment-, and Patient-Centered Care Unite

Did you know 59% of patients value doctors asking about their information needs and desired level of care involvement? Join us to explore these and other insights in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL).

Credit available for this activity expires: 7/5/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001303?ecd=bdc_podcast_libsyn_mscpedu